| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 2 | 1 | 3 | 1 |
| Cost of sales | 1 | 4 | 4 | 2 |
| Gross profit (loss) | 1 | -3 | -1 | -1 |
| Research and development expenses | 2 | 221 | - | 159 |
| Sales and marketing expenses | 25 | 32 | 17 | 153 |
| General and administrative expenses | 211 | 97 | 111 | 298 |
| Research and development expenses | - | - | -6 | - |
| Operating loss | -237 | -353 | -123 | -610 |
| Financial expenses, net | - | -11 | 1 | - |
| Change in fair value of convertible loans and warrant liability | -3,993 | 358 | -44 | 139 |
| Financial (expenses) income, net | -3 | - | - | - |
| Loss before income tax benefit | - | - | -166 | -512 |
| Other expenses | 445 | - | - | 41 |
| Net profit (loss) | -4,678 | -6 | -166 | -512 |
| Net profit (loss) attributable to appyea inc | -4,678 | -6 | -166 | -512 |
| Basic | 0 | 0 | -0 | 0 |
| Diluted | 0 | 0 | -0 | 0 |
| Weighted average number of common shares outstanding basic | 564,425,141 | 534,758,474 | 527,945,974 | 483,923,616 |
| Weighted average number of common shares outstanding diluted | 564,425,141 | 534,758,474 | 527,945,974 | 483,923,616 |
APPYEA, INC (APYP)
APPYEA, INC (APYP)